Product Information
NYLIA 7-7-7-28 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2346 per EA under NDC 65862089788. Its NADAC has been published 263 times since Aug 11, 2021.
FDA first approved this application on Oct 21, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Aurobindo Pharma LimitedNDC
65862089788
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA207054FDA Approved
10/21/2016
TE Code
AB
On Market Since
10/21/2016
Price Statistics
The NADAC for NYLIA 7-7-7-28 TABLET has been published 263 times since Aug 11, 2021, and over the history we have for it it has declined 37.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2346 per EA |
|---|---|
| All-time high | $0.5336 (Feb 15, 2023) |
| All-time low | $0.1916 (Nov 20, 2024) |
| 52-week high | $0.2985 |
| 52-week low | $0.2346 |
| Median price | $0.2903 |
| Average price | $0.3103 |
| Largest weekly change | -36.8% (May 17, 2023) |
| Weeks tracked | 263 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYLIA 7-7-7-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NYLIA 7-7-7-28 TABLET, manufactured by Aurobindo Pharma Limited, is $0.2346 per EA (NDC 65862089788), effective Aug 19, 2026.
How has the price of NYLIA 7-7-7-28 TABLET changed over time?
Over the history we have for it, the NADAC for NYLIA 7-7-7-28 TABLET has declined 37.1%. It has been tracked across 263 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for NYLIA 7-7-7-28 TABLET?
Since Aug 11, 2021, the NADAC for NYLIA 7-7-7-28 TABLET has ranged from a low of $0.1916 (Nov 20, 2024) to a high of $0.5336 (Feb 15, 2023), with a median of $0.2903 per EA.
Are there cheaper alternatives to NYLIA 7-7-7-28 TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYLIA 1-35 28 TABLET, is $0.2116 per EA — about 10% below NYLIA 7-7-7-28 TABLET.
Who manufactures NYLIA 7-7-7-28 TABLET?
NYLIA 7-7-7-28 TABLET (NDC 65862089788) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.